Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanreotide Autogel for dumping syndrome after gastric surgery
2007-001078-94Phase 4Terminated
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2007
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, single-arm trial of lanreotide in dumping syndrome, sponsored by Radboud University Medical Center. Primary endpoint: Primary efficacy endpoint. Started Apr 2007; status: terminated.
02
Drugs
lanreotide
03
Conditions
dumping syndrome
Beyond the preview
Go deeper on 2007-001078-94.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001078-94.